Precision BioSciences, Inc.
DTIL
$5.04
-$0.09-1.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -561.16% | 20.54% | 111.69% | 111.73% | 118.98% |
| Total Depreciation and Amortization | -50.49% | -47.93% | -44.55% | -40.09% | -30.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 130.14% | -18.91% | -255.12% | -148.75% | -144.02% |
| Change in Net Operating Assets | 109.24% | 25.30% | -30.16% | 3.79% | -2,904.74% |
| Cash from Operations | 2.22% | 18.31% | 30.52% | 50.60% | -44.44% |
| Capital Expenditure | 57.38% | 85.02% | 87.23% | 95.14% | 85.72% |
| Sale of Property, Plant, and Equipment | -94.85% | -100.00% | -43.93% | 38.57% | 38.57% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -103.66% | -103.49% | -100.33% | 2,751.33% | 3,271.60% |
| Cash from Investing | -106.45% | -107.71% | -103.69% | -101.47% | 315.83% |
| Total Debt Issued | -- | -- | -- | 449,860.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -41.14% | -52.92% | 831.32% | 1,723.52% | 1,579.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -70.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.18% | -52.97% | 836.51% | 1,750.64% | 1,706.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -172.55% | -86.47% | 88.74% | 98.99% | 69.31% |